Membranous Tonsilitis as a Clinical Presentation of Acute Monocytic Leukemia: A Rare Case Report
DOI:
https://doi.org/10.30742/jikw.v14i2.4290Keywords:
Acute monocytic leukemia (AML-M5), Acute myeloid leukemia (AML) tonsilitis, Extramedullary manifestationAbstract
Background: Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal proliferation of immature myeloid precursor cells in the bone marrow and peripheral circulation. Hematologic manifestations such as anemia, thrombocytopenia, and leukocytosis are welldocumented, its association with oral involvement, particularly tonsillitis, is a rare presenting feature. Objective: This case report emphasizes membranous tonsilitis as the primary presenting feature in acute monocytic leukemia (AML-M5). The aim of writing this case study is to provide an illustration that the causes of membranous tonsillitis, beside from the infection, can also be caused by infiltration of leukemia cells. Case Presentation: We report a case of a 27-year-old female presented with fever and was found to have a fluctuating mass on the right side of the neck along with gingival swelling and hyperemic, hypertrophic tonsils with a membranous exudate. The diagnosis from bone marrow aspiration and immunophenotyping revealed as acute monocytic leukemia (AML-M5). Bacterial and fungal infections were excluded through gram staining, potassium hydroxide (KOH) examination, and throat swab culture. The patient was initially stabilized with hydroxyurea, with subsequent clinical improvement, before being referred to a tertiary center for definitive management. Result: This diagnostic workup altogether from all the clinicians leads to the diagnosis of acute myeloid leukemia (AML-M5). Conclusion: This case highlights primary tonsilitis as the primary presenting feature of acute myeloid leukemia (AML-M5), emphasizing the need for continued monitoring and regular follow-up assessment to detect potential relapses and ensure optimal disease managementReferences
Abelson, S. et al. 2018. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559(7714), p. 400. https://doi.org/10.1038/s41586-018-0317-6.
Ally, F. and Chen, X. 2024. Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry. Cancers 16(22). https://doi.org/10.3390/cancers16223855
Anderson, J. and Paterek, E. 2023. Tonsillitis. StatPearls. Available at:
https://www.ncbi.nlm.nih.gov/books/NBK544342/ [Accessed: 8 February 2025].
Basharat, M., Khan, S.A., Nasir Ud Din and Ahmed, D. 2019. Immunophenotypic characterisation of
morphologically diagnosed cases of Acute Myeloid Leukaemia (AML). Pakistan Journal of Medical Sciences 35(2), p. 470. https://doi.org/10.12669/pjms.35.2.614
Blau, O. and Blau, O. 2015. Gene Mutations in Acute Myeloid Leukemia — Incidence, Prognostic Influence, and Association with Other Molecular Markers. Leukemias - Updates and New
Insights. https://doi.org/10.5772/60928
Bruserud, Ø., Selheim, F., Hernandez-Valladares, M. and Reikvam, H. 2024. Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial
Metabolism, Resistance to and Induction by Targeted Therapies. International Journal of Molecular Sciences 25(12), p. 6356. https://doi.org/10.3390/ijms25126356
Bullinger, L., Döhner, K. and Dohner, H. 2017. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology 35(9), pp. 934–946. https://doi.org/10.1200/jco.2016.71.2208
Capelli, D., Menotti, D., Fiorentini, A., Saraceni, F. and Olivieri, A. 2022. Secondary Acute Myeloid Leukemia: Pathogenesis and Treatment. Leukemia, pp. 111–127.
https://doi.org/10.36255/exon-publications-leukemia-secondary-acute-myeloid-leukemia
Chennamadhavuni, A., Lyengar, V., Mukkamalla, S.K.R. and Shimanovsky, A. 2023. Leukemia. Available at: https://www.ncbi.nlm.nih.gov/books/NBK560490/ [Accessed: 7 February 2025].
Döhner, H. et al. 2016. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4), p. 424. https://doi.org/10.1182/blood-2016-08-
Döhner, H. et al. 2022. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12), pp. 1345–1377. https://dx.doi.org/10.1182/blood.2022016867
Hasserjian, R.P. 2021. Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia. Best Practice and Research: Clinical Haematology 34(1). doi:
https://10.1016/j.beha.2021.101249
Jain, S. and Sharma, R. 2024. Laboratory Evaluation of Bone Marrow. StatPearls. Available at: https://www.ncbi.nlm.nih.gov/books/NBK603716/ [Accessed: 7 February 2025].
El Jamal, S.M., Najfeld, V., Coltoff, A. and Navada, S. 2022. Myelodysplastic Syndrome. Atlas of Diagnostic Hematology, pp. 98–109. Available at:
https://www.ncbi.nlm.nih.gov/books/NBK534126/ [Accessed: 7 February 2025].
Jawed, Md.A. et al. 2024. An Extensive Analysis and Comparison of Bone Marrow Aspiration and Bone Marrow Trephine Biopsy at a Tertiary Care Hospital in Jharkhand for Various Hematological
and Non-hematological Illnesses. Cureus 16(6), p. e62661. Available at:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11258562/ [Accessed: 7 February 2025].
Khammissa, R.A.G., Fourie, J., Masilana, A., Lawrence, S., Lemmer, J. and Feller, L. 2017. Oral manifestations of thrombocytopaenia. The Saudi Dental Journal 30(1), p. 19. Available at:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6112372/ [Accessed: 8 February 2025].
Knottenbelt, D.C., Patterson-Kane, J.C. and Snalune, K.L. 2015. Tumours of the cardiovascular system. Clinical Equine Oncology, pp. 512–543. doi: 10.1016/B978-0-7020-4266-9.00030-1.
Masoumi-Dehshiri, R., Hashemi, A., Neamatzadeh, H. and Zare-Zardeini, H. 2014. A Case Report: Acute Myeloid Leukemia (FAB M7). Iranian Journal of Pediatric Hematology and Oncology 4(4), p.
Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC4293519/ [Accessed: 7
February 2025].
Musiałek, M.W. and Rybaczek, D. 2021. Hydroxyurea-The Good, the Bad and the Ugly. Genes 12(7). Available at: https://pubmed.ncbi.nlm.nih.gov/34356112/ [Accessed: 8 February 2025].
Quispe, R.A., Aguiar, E.M., de Oliveira, C.T., Neves, A.C.X. and Santos, P.S. da S. 2022. Oral manifestations of leukemia as part of early diagnosis. Hematology, transfusion and cell therapy 44(3), pp. 392–401. Available at: https://pubmed.ncbi.nlm.nih.gov/34862157/
[Accessed: 7 February 2025].
Sasaki, K. et al. 2021. De novo acute myeloid leukemia: A population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database,
to 2017. Cancer 127(12), pp. 2049–2061. Available at:
https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.33458 [Accessed: 6 February 2025].
Shallis, R.M., Wang, R., Davidoff, A., Ma, X. and Zeidan, A.M. 2019. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges. Blood reviews 36, pp. 70–87. Available
at: https://pubmed.ncbi.nlm.nih.gov/31101526/ [Accessed: 6 February 2025].
Singh, P., Sharma, K., Maheshwari, A. and Sharma, S. 2022. Case Report Hemophagocytic lymphohistiocytosis secondary to T-cell Acute Lymphoblastic Leukemia with membranous tonsillitis. Iran J Ped Hematol Oncol. 2022 12(4), pp. 303–307. doi:
http://10.18502/ijpho.v12i4.10919
Stella, S. et al. 2021. Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes. International Journal of Molecular Sciences 22(2), pp. 1–22.
doi: http://10.3390/ijms22020486
Vakiti, A., Reynolds, S.B. and Mewawalla, P. 2024. Acute Myeloid Leukemia. StatPearls. Available at: https://www.ncbi.nlm.nih.gov/books/NBK507875 / [Accessed: 6 February 2025].
Wachter, F. and Pikman, Y. 2024. Pathophysiology of Acute Myeloid Leukemia. Acta Haematologica 147(2), pp. 229–246. Available at: https://dx.doi.org/10.1159/000536152 [Accessed: 7
February 2025].
Xing, S. et al. 2019. Cytogenetics and associated mutation profile in patients with acute monocytic leukemia. International Journal of Laboratory Hematology 41(4), pp. 485–492. Available at:
https://onlinelibrary.wiley.com/doi/full/10.1111/ijlh.13030 [Accessed: 7 February 2025]
Downloads
Additional Files
Published
Issue
Section
License
The journal operates an Open Access policy under a Creative Commons Attribution-NonCommercial 4.0 International License. Author continues to retain the copyright if the article is published in this journal. The publisher will only need publishing rights. (CC-BY-NC 4.0)